PE-TargetDisk

The PE-TargetDisk (RUO) enables the measurement of NOS2 and CCL27 from fresh skin samples directly in your doctor's office, providing objective molecular insights into unclear cases of inflammatory skin diseases. Move from interpretation to a biologically grounded understanding!

From uncertainty to insight within a single consultation

Molecular signatures for dermatologists. Directly in your doctor's office!

The differentiation between psoriasis and eczema remains a daily challenge in dermatology remains a daily challenge in dermatology, particularly in unclear or overlapping cases. The biomarkers NOS2 and CCL27 have been widely studied for their role in distinguishing these inflammatory skin diseases at a molecular level.

PE-TargetDisk (RUO) enables the measurement of these biomarkers from a minimal fresh skin sample, providing objective insight into the underlying inflammatory patterns in unclear cases. Results are available within hours, not days. 

This allows dermatologists to go beyond visual and clinical interpretation to gain a deeper, biology-based understanding of the patient’s skin

Adding objective insight where traditional dermatology reach its limits

Fast and simple sample-to-result workflow with minimal effort, maximum results, and more clarity for patients. 

KEY BENEFITS:

Molecular support for inflammatory dermatoses in unclear cases 
✔ Fast and simple workflow — minimal effort, rapid results
✔ Patient-friendly sampling — no biopsy required
✔ Designed for use directly in dermatology practices

 

WORKFLOW:

Simple. Fast. Practice-ready.

  • Tissue type: Fresh skin samples
  • Sampling: Quick and patient-friendly using a curette (no biopsy required)
  • Transfer: Minimal sample applied directly to the disk
  • Measurement: <3 minutes hands-on time
  • Seamless integration: The application is designed for fresh skin samples and can be seamlessly integrated into your practice thanks to the spacesaving Analyzer
  • Result: Objective molecular information within hours. Sample in. Insight out.

Scientifically validated biomarkers for psoriasis and eczema

Beyond visual interpretation alone. The science behind the molecular support for your daily work processes

To better understand inflammatory skin diseases, a study by Quaranta et al.(2014)  analyzed gene expression patterns directly from patient skin.

Key findings:

  • Distinct molecular signatures for psoriasis and eczema
  • Biomarkers NOS2 and CCL27 reflect different immune pathways
  • Reliable differentiation between both conditions
  • Improved diagnostic confidence in unclear cases

Each disease shows a unique molecular fingerprint!

Why is this important?

The molecular approach provided additional insight beyond clinical and histological assessment alone, especially where conventional methods reach their limits.

Discover how the PE-TargetDisk (RUO) can support your workflow molecular insights!

You are currently viewing a placeholder content from Default. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

More Information

Do you want to learn more?

Contact our sales team or click the button below!
info@dermagnostix.com